Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 990 | 41 | 111 | 108 | 58 |
| Receivables | 2 | 0 | N/A | N/A | N/A |
| Inventories | 24 | 16 | N/A | N/A | N/A |
| Other current assets | 8 | 8 | 990 | 0 | 0 |
| TOTAL | $1,026 | $66 | $1,101 | $117 | $59 |
| Non-Current Assets | |||||
| PPE Net | 20 | 33 | 45 | 60 | 6 |
| Other Non-Current Assets | 0 | 0 | 0 | 80 | 0 |
| TOTAL | $20 | $33 | $45 | $140 | $6 |
| Total Assets | $1,046 | $98 | $1,147 | $258 | $64 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 63 | 97 | 116 | 19 | 28 |
| Accrued Expenses | 24 | 21 | 684 | 9 | 9 |
| TOTAL | $1,051 | $834 | $913 | $751 | $274 |
| Non-Current Liabilities | |||||
| Long Term Debt | 949 | N/A | 290 | 80 | N/A |
| TOTAL | $949 | $N/A | $290 | $80 | $N/A |
| Total Liabilities | $2,000 | $834 | $1,202 | $831 | $274 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 35 | 45 | 474 | 426 |
| Common Shares | 2 | 35 | 4 | 46 | 769 |
| Retained earnings | -20,219 | -17,435 | -15,774 | -13,618 | -12,578 |
| Other shareholders' equity | -3 | -3 | -4 | 1 | 0 |
| TOTAL | $-955 | $-735 | $-56 | $-573 | $-210 |
| Total Liabilities And Equity | $1,046 | $98 | $1,147 | $257 | $64 |